Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 590848, 8 pages
http://dx.doi.org/10.1155/2014/590848
Research Article

In Vitro Dissolution and In Vivo Bioavailability of Six Brands of Ciprofloxacin Tablets Administered in Rabbits and Their Pharmacokinetic Modeling

1Department of Pharmaceutical Sciences, Faculty of Pharmacy, Helwan University, Cairo 11790, Egypt
2Department of Pharmacology and Toxicology, Dubai Pharmacy College, P.O. Box 19099, Dubai, UAE

Received 7 February 2014; Revised 17 May 2014; Accepted 18 May 2014; Published 3 June 2014

Academic Editor: René Holm

Copyright © 2014 Sahar Fahmy and Eman Abu-Gharbieh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Olaniyi, C. Babalola, F. Oladeinde, and A. Adegoke, “Towards better quality assurance of drugs,” in Proceedings of the 4th National Workshop, pp. 70–73, 2001.
  2. H. Shah, “Generic captures new prescription markets,” Perspectives in Pharmacy Economics, vol. 199, no. 4, p. 3, 2013. View at Google Scholar
  3. J. P. Remington, Remington's Pharmaceutical Sciences, Mack, 18th edition, 1990.
  4. A. A. Olaniyi, “Towards better quality assurance of drugs and food,” in Proceedings of the National Workshop, pp. 123–135, 1993.
  5. World Health Organization, WHO Medicines Strategy, Countries at the Core 2004–2007, 2004.
  6. US Food and Drug Administration, Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations, 2003.
  7. S. Rani, “Bioequivalence: issues and perspectives,” Indian Journal of Pharmacology, vol. 39, no. 5, pp. 218–225, 2007. View at Google Scholar · View at Scopus
  8. V. Shah, “Dissolution: a quality control test vs a bioequivalent test,” Dissolution Technologies, vol. 8, no. 4, pp. 1–2, 2001. View at Google Scholar
  9. V. Andriole, “Clinical overview of the newer 4-quinolone antibacterial agents,” in The Quinolones, pp. 155–200, Academic Press, London, UK, 1988. View at Google Scholar
  10. H. C. Neu, “Ciprofloxacin: a major advance in quinolone chemotherapy,” American Journal of Medicine A, vol. 82, supplement 4, pp. 1–404, 1987. View at Google Scholar
  11. D. M. Campoli-Richards, J. P. Monk, A. Price, P. Benfield, P. A. Todd, and A. Ward, “Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use,” Drugs, vol. 35, no. 4, pp. 373–447, 1988. View at Google Scholar · View at Scopus
  12. J. M. Hyatt, D. E. Nix, and J. J. Schentag, “Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 12, pp. 2730–2737, 1994. View at Google Scholar · View at Scopus
  13. A. M. Abd El-Aty, A. Goudah, M. Ismail, and M. Shimoda, “Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural,” Veterinary Research Communications, vol. 29, no. 4, pp. 297–304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. US Food and Drug Administration, “Cipro1 (ciprofloxacin hydrochloride tablets) Cipro1 (ciprofloxacin ) oral suspension,” 2013.
  15. Bayer health care under lenience of Schering Corporation, “Cipro1 medication guide revised October 2008,” 2008.
  16. US Food and Drug Administration, Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, 1997.
  17. D. L. Kordick, M. G. Papich, and E. B. Breitschwerdt, “Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 11, pp. 2448–2455, 1997. View at Google Scholar · View at Scopus
  18. M. Gibaldi and D. Perrier, Pharmacokinetics, Marcel Dekker, New York, NY, USA, 2nd edition, 1982.
  19. K. Yamaoka, T. Nakagawa, and T. Uno, “Statistical moments in pharmacokinetics,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 6, no. 6, pp. 547–558, 1978. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-Y. Wu and L. Z. Benet, “Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system,” Pharmaceutical Research, vol. 22, no. 1, pp. 11–23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. US Food and Drug Administration, Guidance for Industry—Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, 2013.
  22. M. C. Gohel, K. G. Sarvaiya, A. R. Shah, and B. K. Brahmbhatt, “Mathematical approach for the assessment of similarity factor using a new scheme for calculating weight,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 2, pp. 142–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Costa, “An alternative method to the evaluation of similarity factor in dissolution testing,” International Journal of Pharmaceutics, vol. 220, no. 1-2, pp. 77–83, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Muňoz, P. Llovería, M. P. Santos, A. R. Abadía, J. J. Aramayona, and M. A. Bregante, “Pharmacokinetics of ciprofloxacin in sheep after single intravenous or intramuscular administration,” Veterinary Quarterly, vol. 18, no. 2, pp. 45–48, 1996. View at Google Scholar · View at Scopus
  25. R. Raina, S. Prawez, D. J. Dimitrova, N. K. Pankaj, and P. K. Verma, “Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration,” Journal of Veterinary Science, vol. 9, no. 3, pp. 241–245, 2008. View at Google Scholar · View at Scopus
  26. A. R. Abadia, J. J. Aramayona, M. J. Munoz, J. M. Pla Delfina, M. P. Saez, and M. A. Bregante, “Disposition of ciprofloxacin following intravenous administration in dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 17, no. 5, pp. 384–388, 1994. View at Google Scholar · View at Scopus
  27. J. F. Nouws, D. J. Mevius, T. B. Vree, A. M. Baars, and J. Laurensen, “Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs,” Veterinary Quarterly, vol. 10, no. 3, pp. 156–163, 1988. View at Google Scholar · View at Scopus
  28. M. J. Muňoz, P. Llovería, M. P. Santos, A. R. Abadía, J. J. Aramayona, and M. A. Bregante, “Pharmacokinetics of ciprofloxacin in sheep after single intravenous or intramuscular administration,” Veterinary Quarterly, vol. 18, no. 2, pp. 45–48, 1996. View at Google Scholar · View at Scopus
  29. A. Mohan and S. K. Garg, “Disposition kinetics of ciprofloxacin following a single intravenous dose in calves,” Indian Journal of Pharmacology, vol. 35, no. 4, pp. 227–231, 2003. View at Google Scholar · View at Scopus
  30. O. A. Adegbolagun, O. A. Olalade, and S. E. Osumah, “Comparative evaluation of the biopharmaceutical and chemical equivalence of some commercially available brands of ciprofloxacin hydrochloride tablets,” Tropical Journal of Pharmaceutical Research, vol. 6, no. 3, pp. 737–745, 2007. View at Google Scholar
  31. B. Pécoul, P. Chirac, P. Trouiller, and J. Pinel, “Access to essential drugs in poor countries: a lost battle?” Journal of the American Medical Association, vol. 281, no. 4, pp. 361–367, 1999. View at Publisher · View at Google Scholar · View at Scopus